Birkenstock Holding plc (NYSE:BIRK – Free Report) – William Blair reduced their Q4 2024 earnings per share estimates for Birkenstock in a research note issued on Tuesday, December 10th. William Blair analyst S. Zackfia now expects that the company will post earnings of $0.24 per share for the quarter, down from their prior forecast of $0.25. The consensus estimate for Birkenstock’s current full-year earnings is $1.36 per share. William Blair also issued estimates for Birkenstock’s Q2 2025 earnings at $0.60 EPS, Q3 2025 earnings at $0.69 EPS, Q4 2025 earnings at $0.37 EPS, FY2025 earnings at $1.83 EPS and Q1 2026 earnings at $2.41 EPS.
Other equities analysts have also recently issued research reports about the company. Telsey Advisory Group reissued an “outperform” rating and issued a $70.00 price objective on shares of Birkenstock in a report on Friday. Stifel Nicolaus increased their target price on Birkenstock from $63.00 to $70.00 and gave the company a “buy” rating in a research report on Friday, August 23rd. HSBC raised shares of Birkenstock from a “hold” rating to a “buy” rating and raised their price target for the company from $58.00 to $60.00 in a research note on Tuesday, December 3rd. Hsbc Global Res raised Birkenstock to a “strong-buy” rating in a research note on Tuesday, December 3rd. Finally, Evercore ISI reiterated an “outperform” rating and set a $77.00 price target (up previously from $63.00) on shares of Birkenstock in a report on Monday, August 26th. Two analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $66.13.
Birkenstock Stock Up 2.7 %
NYSE:BIRK opened at $55.06 on Friday. The company has a debt-to-equity ratio of 0.55, a current ratio of 2.91 and a quick ratio of 1.49. The company’s fifty day moving average price is $49.31 and its 200-day moving average price is $53.01. Birkenstock has a 1-year low of $41.00 and a 1-year high of $64.78. The firm has a market capitalization of $10.34 billion, a P/E ratio of 90.26, a PEG ratio of 1.19 and a beta of 2.22.
Institutional Trading of Birkenstock
Several institutional investors and hedge funds have recently made changes to their positions in the stock. Quarry LP purchased a new stake in shares of Birkenstock during the third quarter worth about $25,000. MetLife Investment Management LLC lifted its holdings in shares of Birkenstock by 52.2% during the 3rd quarter. MetLife Investment Management LLC now owns 688 shares of the company’s stock worth $34,000 after acquiring an additional 236 shares during the period. GAMMA Investing LLC boosted its position in shares of Birkenstock by 33.7% in the third quarter. GAMMA Investing LLC now owns 893 shares of the company’s stock worth $44,000 after acquiring an additional 225 shares during the last quarter. Amalgamated Bank increased its position in Birkenstock by 51.8% during the third quarter. Amalgamated Bank now owns 2,071 shares of the company’s stock worth $102,000 after purchasing an additional 707 shares during the last quarter. Finally, Acadian Asset Management LLC purchased a new position in Birkenstock during the second quarter worth approximately $136,000. 19.93% of the stock is currently owned by hedge funds and other institutional investors.
Birkenstock Company Profile
Birkenstock Holding plc manufactures and sells footwear products. It also offers sandals, shoes, closed-toe silhouettes, skincare products, and accessories. The company sells its products through e-commerce sites and a network of owned retail stores, as well as business-to-business channels. It operates in the United States, Brazil, Canada, Mexico, Europe, APMA, and internationally.
Recommended Stories
- Five stocks we like better than Birkenstock
- The 3 Best Fintech Stocks to Buy Now
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What Are Treasury Bonds?
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Birkenstock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Birkenstock and related companies with MarketBeat.com's FREE daily email newsletter.